Evidence map›Paper›PMID 15208453›Full record

ArticleMolecular biotechnology2004

The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response.

Gemma Armengol, Lina Maria Ruiz, Sergio Orduz

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Linear DNA amplicons as a novel cancer vaccine strategy.Journal of experimental & clinical cancer research : CR · 2022
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. A DNA vaccine against Escherichia coli O157:H7.Iranian biomedical journal · 2012
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gemma ArmengolBiotechnology and Biological COntrol Unit, Corporación para Investigaciones Biológicas, AA 7378, Medellín, Colombia.
Lina Maria Ruiz
Sergio Orduz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The duration of the immune response against any vaccine is critical. The present study was performed to determine the stability of injected plasmid deoxyribonucleic acid (DNA), the duration of gene expression in mouse muscle, as well as the duration of the immune response generated in mice after injection of plasmid pSO2C1 harboring the cry11Bb gene of Bacillus thuringiensis serovar. medellin. The localization and the persistence of the inoculated gene were determined by in situ hybridization and polymerase chain reaction (PCR). The results demonstrated that plasmid DNA can persist in mouse muscle for up to 2 yr. Moreover, immunohistochemical analysis showed that Cry11Bb protein was expressed for the lifetime of the mice at a low but significant level. Finally, production of Cry11Bb-specific antibodies in mice injected with pSO2C1 was high and durable as significant antibody titers were observed up to 119 wk after injection of the plasmid. This persistent immune response is likely owing to the existence of a protein and/or DNA depot in the organism, which serves to maintain the immune response, acting as a secondary or booster immunization.

Indexed as

DNAGene Expression RegulationGenetic TechniquesAnimalsAntibody FormationBacterial ProteinsBacterial ToxinsEnzyme-Linked Immunosorbent AssayEpitopesImmunityImmunohistochemistryIn Situ HybridizationMiceMusclesPlasmidsPolymerase Chain ReactionBacterial ProteinsBacterial ToxinsCRY11BB protein, Bacillus thuringiensisDNAEpitopesVaccines, DNA

Identifiers

PMID15208453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.